Constanta Timcheva
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 5
- PARP inhibition in cancer therapy 5
- Cancer Treatment and Pharmacology 4
- Lung Cancer Research Studies 4
- Colorectal Cancer Treatments and Studies 3
-
- Advanced Breast Cancer Therapies 3
-
- Ovarian cancer diagnosis and treatment 5
-
- BRCA gene mutations in cancer 6
Constanta Timcheva
22 papers receiving 463 citations
Peers
Comparison fields: 5 of 64
- Oncology 384
- Cancer Research 124
- Pulmonary and Respiratory Medicine 94
- Geriatrics and Gerontology 9
- Reproductive Medicine 19
Countries citing papers authored by Constanta Timcheva
This map shows the geographic impact of Constanta Timcheva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constanta Timcheva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constanta Timcheva more than expected).
Fields of papers citing papers by Constanta Timcheva
This network shows the impact of papers produced by Constanta Timcheva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constanta Timcheva. The network helps show where Constanta Timcheva may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Constanta Timcheva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 12 | |
| 4 | 2022 | 2 | |
| 5 | 2021 | 7 | |
| 6 | 2021 | 4 | |
| 7 | 2020 | 1 | |
| 8 | 2020 | 47 | |
| 9 | 2020 | 1 | |
| 10 | 2019 | 2 | |
| 11 | 2017 | 5 | |
| 12 | 2016 | 9 | |
| 13 | 2016 | 2 | |
| 14 | 2015 | 2 | |
| 15 | 2013 | 105 | |
| 16 | 2012 | 2 | |
| 17 | 2011 | 197 | |
| 18 | 2010 | 12 | |
| 19 | 2009 | 14 | |
| 20 | 1996 | 13 |
About Constanta Timcheva
Constanta Timcheva is a scholar working on Oncology, Reproductive Medicine, Cancer Research, Genetics and Pulmonary and Respiratory Medicine, having authored 23 papers that have together received 474 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Ovarian cancer diagnosis and treatment (5 papers), PARP inhibition in cancer therapy (5 papers), Cancer Treatment and Pharmacology (4 papers), Lung Cancer Research Studies (4 papers), Advanced Breast Cancer Therapies (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Oncology (384 citations), Cancer Research (124 citations), Pulmonary and Respiratory Medicine (94 citations), Geriatrics and Gerontology (9 citations) and Reproductive Medicine (19 citations). Constanta Timcheva has collaborated with scholars based in United Kingdom, Bulgaria and Hungary. Frequent co-authors include Niall C. Tebbutt, G. Pover, David R. Spigel, Tudor–Eliade Ciuleanu, Phillip J. Stella, G. Bodoky, J. Eglītis, Piotr Zaborek, Tadeusz Pieńkowski and Jozef Mardiak. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Gynecologic Oncology, Annals of Oncology and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.